Advanced Pharmacotherapeutics in Psychiatric and Neurological Disorders
PostgraduateTAS-CSA7262026
Course information for 2026 intake View information for 2025 course intake
- Study method
- 100% online
- Assessments
- 100% online
- Enrol by
- 28 June 2026
- Entry requirements
- Part of a degree
- Duration
- 12 weeks
- Price from
- $2,862
- Upfront cost
- $0
- Loan available
- HECS-HELP and FEE-HELP available
Advanced Pharmacotherapeutics in Psychiatric and Neurological Disorders
About this subject
Upon successful completing this subject, the student should be able to:
- Create a search strategy to collate evidence-based psychiatric or neurological related research.
- Critically evaluate and optimise medication therapy in psychiatric and neurological conditions.
- Apply pharmacotherapeutic knowledge and clinical judgement to clinical scenarios.
- Communicate evidence-informed decisions in psychiatric and neurological therapeutics.
- Refer to MyLO for study topics
TAS-CSA726 is a self-directed, fully online subject, that explores a variety of disease states and their management, using a series of patient cases linked to assignment-based questions, to enable the student to enhance their knowledge in the area of clinical pharmacy and pharmaceutical care.
The subject covers the medication management and clinical pharmacy issues in psychiatric and neurological disorders.
- Scoping Review Presentation (50%)
- Short Case with Targeted Responses (20%)
- Clinical Case Review: Comparative Analysis of Multiple Cases (30%)
For textbook details check your university's handbook, website or learning management system (LMS).
Wherever you are, the University of Tasmania brings its island campus to you through a growing range of online programs across art and design, business, education, health, science, sustainability, technology, and more. It’s never too late to switch things up. Kickstart that career you’ve been dreaming about, or upskill for the one you’re in. You’ll also become a part of the world's leading university on climate action.
Learn more about UTAS.
Explore UTAS courses.
- QS World University Ranking 2026, within Australia:
- 20
- Times Higher Education World University Ranking 2026, within Australia:
- 14
Entry requirements
Part of a degree
To enrol in this subject you must be accepted into one of the following degrees:
Elective
- TAS-CPH-GDI-2026 - Graduate Diploma of Clinical Pharmacy
- TAS-CPH-GCE-2026 - Graduate Certificate in Clinical Pharmacy
Prior study
You must either have successfully completed the following subject(s) before starting this subject, or enrol in the following subject(s) to study at the same time or prior to this subject:
one of
TAS-CSA721 (Not currently available)
- TAS-CSA731-Evidence Based Pharmacotherapeutic Practice
Additional requirements
No additional requirements
Study load
- 0.125 EFTSL
- This is in the range of 10 to 12 hours of study each week.
Equivalent full time study load (EFTSL) is one way to calculate your study load. One (1.0) EFTSL is equivalent to a full-time study load for one year.
Find out more information on Commonwealth Loans to understand what this means to your eligibility for financial support.
Related degrees
Once you’ve completed this subject it can be credited towards one of the following courses
Graduate Diploma of Clinical Pharmacy
PostgraduateTAS-CPH-GDI
Graduate Certificate in Clinical Pharmacy
PostgraduateTAS-CPH-GCE